ALDX: Aldeyra Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 375.57
Enterprise Value ($M) 336.07
Book Value ($M) 71.00
Book Value / Share 1.19
Price / Book 5.29
NCAV ($M) 70.47
NCAV / Share 1.18
Price / NCAV 5.33

Profitability (mra)
Return on Invested Capital (ROIC) -0.65
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.47

Liquidity (mrq)
Quick Ratio 5.59
Current Ratio 5.59

Balance Sheet (mrq) ($M)
Current Assets 104.07
Assets 104.61
Liabilities 33.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -60.12
Net Income -55.85
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -43.21
Cash from Investing -44.92
Cash from Financing -0.17

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Perceptive Advisors Llc 15.60 7.94
2024-02-13 13G Vanguard Group Inc 6.68

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 98,488 534,317 18.43
2025-03-06 86,266 446,349 19.33
2025-03-05 98,674 455,748 21.65
2025-03-04 147,628 857,269 17.22

(click for more detail)

Similar Companies
AKAN – Akanda Corp. AKBA – Akebia Therapeutics, Inc.
ALBT – Avalon GloboCare Corp. ALGS – Aligos Therapeutics, Inc.
ALTS – JanOne Inc.


Financial data and stock pages provided by
Fintel.io